Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells

BMC Cell Biology

Volumn 11, Issue , 2010, Pages

  Suzuki, Hirohiko ^a   Shibata, Rei ^a   Kito, Tetsutaro ^a   Ishii, Masakazu ^a   Li, Ping ^a   Yoshikai, Toru ^a   Nishio, Naomi ^a   Ito, Sachiko ^a   Numaguchi, Yasushi ^a   Yamashita, Jun K ^b   Murohara, Toyoaki ^a   Isobe, Kenichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL SELECTION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; HINDLIMB; ISCHEMIA; LASER DOPPLER FLOWMETRY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVASCULARIZATION; STEM CELL TRANSPLANTATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CELL SEPARATION; DISEASE MODEL; FLOW CYTOMETRY; GENETICS; LIMB; METABOLISM; NUDE MOUSE; PATHOLOGY; TRANSPLANTATION; VASCULARIZATION;

IPS; MUS; MUS MUSCULUS;

ANIMALS; CELL LINE; CELL SEPARATION; DISEASE MODELS, ANIMAL; EXTREMITIES; FLOW CYTOMETRY; INDUCED PLURIPOTENT STEM CELLS; ISCHEMIA; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77956800940     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-11-72     Document Type: Article

References (33)

1. Norgren L, Hiatt W, Dormandy J, Nehler M, Harris K, Fowkes F. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007, 45(Suppl S):S5-67. 10.1016/j.jvs.2006.12.037, 17223489.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner J. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967. 10.1126/science.275.5302.964, 9020076.
3. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner J, Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438. 10.1038/8462, 10202935.
4. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360:427-435. 10.1016/S0140-6736(02)09670-8, 12241713.
5. Kajiguchi M, Kondo T, Izawa H, Kobayashi M, Yamamoto K, Shintani S, Numaguchi Y, Naoe T, Takamatsu J, Komori K, Murohara T. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J 2007, 71:196-201. 10.1253/circj.71.196, 17251666.
6. Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y, Uemura S, Suzuki H, Fukumoto S, et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J 2008, 156:1010-1018. 10.1016/j.ahj.2008.06.025, 19061721.
7. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher A, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-7. 10.1161/hh1301.093953, 11440984.
8. Hill J, Zalos G, Halcox J, Schenke W, Waclawiw M, Quyyumi A, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600. 10.1056/NEJMoa022287, 12584367.
9. Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S, Inden Y, Murohara T. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004, 24:1442-1447. 10.1161/01.ATV.0000135655.52088.c5, 15191940.
10. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676. 10.1016/j.cell.2006.07.024, 16904174.
11. Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S, Yamanaka S, Yamashita J. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008, 118:498-506. 10.1161/CIRCULATIONAHA.108.769562, 18625891.
12. Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier L, Nguemo F, Menke S, Haustein M, Hescheler J, et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 2008, 118:507-517. 10.1161/CIRCULATIONAHA.108.778795, 18625890.
13. Zhang J, Wilson G, Soerens A, Koonce C, Yu J, Palecek S, Thomson J, Kamp T. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009, 104:e30-41. 10.1161/CIRCRESAHA.108.192237, 2741334, 19213953.
14. Nelson T, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009, 120:408-416. 10.1161/CIRCULATIONAHA.109.865154, 2768575, 19620500.
15. Schenke-Layland K, Rhodes K, Angelis E, Butylkova Y, Heydarkhan-Hagvall S, Gekas C, Zhang R, Goldhaber J, Mikkola H, Plath K, MacLellan W. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 2008, 26:1537-1546. 10.1634/stemcells.2008-0033, 2873147, 18450826.
16. Taura D, Sone M, Homma K, Oyamada N, Takahashi K, Tamura N, Yamanaka S, Nakao K. Induction and isolation of vascular cells from human induced pluripotent stem cells--brief report. Arterioscler Thromb Vasc Biol 2009, 29:1100-1103. 10.1161/ATVBAHA.108.182162, 19423866.
17. Assmus B, Honold J, Schachinger V, Britten M, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali N, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355:1222-1232. 10.1056/NEJMoa051779, 16990385.
18. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter D, Martin H, Zeiher A, Dimmeler S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622. 10.1161/01.CIR.0000124476.32871.E3, 15037527.
19. Marion R, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano M, Blasco M. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009, 4:141-154. 10.1016/j.stem.2008.12.010, 19200803.
20. Swijnenburg R, Tanaka M, Vogel H, Baker J, Kofidis T, Gunawan F, Lebl D, Caffarelli A, de Bruin J, Fedoseyeva E, Robbins R. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005, 112:I166-172.
21. Losordo D, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 2004, 109:2692-2697. 10.1161/01.CIR.0000128596.49339.05, 15184293.
22. Tse H, Siu C, Zhu S, Songyan L, Zhang Q, Lai W, Kwong Y, Nicholls J, Lau C. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail 2007, 9:747-753. 10.1016/j.ejheart.2007.03.008, 17481945.
23. Tateno K, Minamino T, Toko H, Akazawa H, Shimizu N, Takeda S, Kunieda T, Miyauchi H, Oyama T, Matsuura K, et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 2006, 98:1194-1202. 10.1161/01.RES.0000219901.13974.15, 16574905.
24. Madeddu P, Emanueli C, Pelosi E, Salis M, Cerio A, Bonanno G, Patti M, Stassi G, Condorelli G, Peschle C. Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 2004, 18:1737-1739.
25. Baba S, Heike T, Yoshimoto M, Umeda K, Doi H, Iwasa T, Lin X, Matsuoka S, Komeda M, Nakahata T. Flk1(+) cardiac stem/progenitor cells derived from embryonic stem cells improve cardiac function in a dilated cardiomyopathy mouse model. Cardiovasc Res 2007, 76:119-131. 10.1016/j.cardiores.2007.05.013, 17560966.
26. Couffinhal T, Silver M, Zheng L, Kearney M, Witzenbichler B, Isner J. Mouse model of angiogenesis. Am J Pathol 1998, 152:1667-1679. 1858441, 9626071.
27. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317. 10.1038/nature05934, 17554338.
28. Shibata R, Skurk C, Ouchi N, Galasso G, Kondo K, Ohashi T, Shimano M, Kihara S, Murohara T, Walsh K. Adiponectin promotes endothelial progenitor cell number and function. FEBS Lett 2008, 582:1607-1612. 10.1016/j.febslet.2008.04.006, 2435501, 18423403.
29. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes J, Fishman M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998, 101:2567-2578. 10.1172/JCI1560, 508846, 9616228.
30. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, Walsh K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 2004, 279:28670-28674. 10.1074/jbc.M402558200, 15123726.
31. Shireman P, Quinones M. Differential necrosis despite similar perfusion in mouse strains after ischemia. J Surg Res 2005, 129:242-250. 10.1016/j.jss.2005.06.013, 16051277.
32. Ieda Y, Fujita J, Ieda M, Yagi T, Kawada H, Ando K, Fukuda K. G-CSF and HGF: combination of vasculogenesis and angiogenesis synergistically improves recovery in murine hind limb ischemia. J Mol Cell Cardiol 2007, 42:540-548. 10.1016/j.yjmcc.2006.11.015, 17223129.
33. Zhang H, Zhang N, Li M, Feng H, Jin W, Zhao H, Chen X, Tian L. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb. Ann Vasc Surg 2008, 22:238-247. 10.1016/j.avsg.2007.07.037, 18083329.